Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 6Oropharyngeal Neoplasms 5Mouth Neoplasms 5Carcinoma 5Laryngeal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Ovarian Neoplasms 3Nasopharyngeal Carcinoma 3Lung Neoplasms 3Hypopharyngeal Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Seminoma 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasm Metastasis 2Ganglioneuroblastoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Adenocarcinoma of Lung 2Wilms Tumor 1Vulvar Neoplasms 1Uterine Neoplasms 1Teratoma 1Stomatitis 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1

Interventions

X-Rays 1Taxes 1Specimen Handling 1Platinum 1Paclitaxel 1Etoposide 1Cisplatin 1Carboplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced NUT Carcinoma × Platinum × Clear all
NCT05019716 2026-05-13

Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma

National Cancer Institute (NCI)

Phase 1/2 Recruiting
36 enrolled

Advanced NUT Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡